Результаты поиска - David Tesarowski

  • Отображение 1 - 5 результаты of 5
Отмена результатов
  1. 1
    Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992)

    Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (... по Dorothy M. Ainsworth, Steven W. Eicker, Amy E. Yeagar, Corinne R. Sweeney, Laurent Viel, David Tesarowski, Jean‐Pierre Lavoie, Andrew M. Hoffman, Mary Rose Paradis, Steven M. Reed, Hollis N. Erb, Elizabeth B. Davidow, Megan E. Nalevanko

    Опубликовано 1998
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    96O Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (T) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2+ breast cancer: Subgroup analysis from KATHERINE

    96O Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (T) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2+ breast cancer: Subgroup analysis... по Sibylle Loibl, Chiun‐Sheng Huang, Max S. Mano, T. Mamounas, Charles E. Geyer, Michael Untch, Gϋnter von Minckwitz, J-C. Thery, Ingo Schwaner, Steven Limentani, Niklas Loman, Kristina Lübbe, J. Chang, Thomas Hatschek, David Tesarowski, Thomas Boulet, Claudia Wiese, Cailu Song, Norman Wolmark

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE

    Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE по Sibylle Loibl, Chiun‐Sheng Huang, Max S. Mano, Eleftherios P. Mamounas, Charles E. Geyer, Michael Untch, Jean‐Christophe Théry, Ingo Schwaner, Steven Limentani, Niklas Loman, Kristina Lübbe, Jenny C. Chang, Thomas Hatschek, David Tesarowski, Chunyan Song, Sanne Lysbet de Haas, Thomas Boulet, Chiara Lambertini, Norman Wolmark

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE

    Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE по Eleftherios P. Mamounas, Michael Untch, Max S. Mano, Chiun‐Sheng Huang, Charles E. Geyer, Gϋnter von Minckwitz, Norman Wolmark, Xavier Pivot, Sherko Küemmel, Michael P. DiGiovanna, Bella Kaufman, G. Kunz, Alison Conlin, Juan Carlos Alcedo, Thorsten Kuehn, Irene Wapnir, Andrea Fontana, John Hackmann, Jonathan Polikoff, Mahasti Saghatchian, Adam Brufsky, Youngsen Yang, Martina Zimovjanová, Thomas Boulet, H. Liu, David Tesarowski, Lisa H. Lam, Chunyan Song, Melanie C. Smitt, Sibylle Loibl

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer по Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano, Sibylle Loibl, Eleftherios P. Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiß, Andrés Redondo, Hans Holger Fischer, William Jacot, Alison Conlin, Claudia Arce-Salinas, Irene Wapnir, Christian Jackisch, Michael P. DiGiovanna, Peter A. Fasching, John Crown, P Wülfing, Zhimin Shao, Elena Rota Caremoli, Haiyan Wu, Lisa H. Lam, David Tesarowski, Melanie C. Smitt, Hannah Douthwaite, Stina Mui Singel, Charles E. Geyer

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: